Vermeulen, Jeroen J. A.
Krivoshein, Georgii
Diware, Sumit
Siddiqi, Muhammad Ali
van den Maagdenberg, Arn M. J. M.
Tolner, Else A.
Hamdioui, Said
Bishnoi, Rajendra
Funding for this research was provided by:
European Union Project DAIS (10100727)
Dutch National Epilepsy Foundation (WAR 22-07)
Corcept Therapeutic
Medical Delta program “Medical NeuroDelta: Ambulant Neuromonitoring for Prevention and Treatment of Brain Disease
European Union Joint Programme– Neurode- generative Disease Research project REBALANCE (1051006221000)
European Union Project NEUROKIT2E (101112268)
TU Delft AI labs program
Article History
Received: 13 March 2025
Accepted: 23 July 2025
First Online: 26 September 2025
Declarations
:
: All animal experimental procedures were approved by the local and national animal ethical committees (i.e., the LUMC Animal Welfare Body and the Dutch Central Authority for Scientific Procedures on Animals CCD (project license AVD11600202317073) following recommendations of the European Communities Council Directive (2010/63/EU) and performed in accordance with ARRIVE guidelines.
: All authors have reviewed and approved the final version of the manuscript and have given their consent for the article to be published.
: Not applicable.
: Not applicable.
: The authors declare no competing interest.